Condition: Pancreatic Neuroendocrine Tumor · Solid Pancreatic Neoplasms · Sponsor: Fudan University
This prospective study aims to evaluate the sensitivity and specificity of an integrated model using fragmentomic profiles of plasma cell-free DNA for early detection of pancreatic neuroendocrine tumors and differential diagnosis of solid pancreatic tumors.
This description comes directly from the study's public registry record.
Xianjun Yu, MD, PhD · 021-64175590-88503 · yuxianjun@fudanpci.org
Shunrong Ji, MD, PhD · 13788993956 · jishunrong@fudanpci.org
Always discuss trial participation with your own doctor first.
| Fudan University shanghai cancer center | Shanghai, Shanghai Municipality, China | Recruiting |
| West China Hospital, Sichuan University | Chengdu, Sichuan, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05847855